Loading...

Kriti Nutrients

BSE:533210
Snowflake Description

Flawless balance sheet and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
533210
BSE
₹944M
Market Cap
  1. Home
  2. IN
  3. Food, Beverage & Tobacco
Company description

Kriti Nutrients Limited engages in the processing, extraction, and production of soya crude/refined oils and products under the KRITI brand in India. The last earnings update was 67 days ago. More info.


Add to Portfolio Compare Print
  • Kriti Nutrients has significant price volatility in the past 3 months.
533210 Share Price and Events
7 Day Returns
-5.4%
BSE:533210
-0.4%
IN Food
-1.2%
IN Market
1 Year Returns
-27.7%
BSE:533210
-5%
IN Food
-4.2%
IN Market
533210 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Kriti Nutrients (533210) -5.4% -13.1% -35.3% -27.7% 4.5% 354.7%
IN Food -0.4% -3% -3.8% -5% 42.4% 118.9%
IN Market -1.2% -2.8% -3.9% -4.2% 19.1% 33.1%
1 Year Return vs Industry and Market
  • 533210 underperformed the Food industry which returned -5% over the past year.
  • 533210 underperformed the Market in India which returned -4.2% over the past year.
Price Volatility
533210
Industry
5yr Volatility vs Market

Value

 Is Kriti Nutrients undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Kriti Nutrients to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Kriti Nutrients.

BSE:533210 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 14.4%
Perpetual Growth Rate 10-Year IN Government Bond Rate 7.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BSE:533210
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year IN Govt Bond Rate 7.6%
Equity Risk Premium S&P Global 8.6%
Food Unlevered Beta Simply Wall St/ S&P Global 0.56
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.565 (1 + (1- 35%) (13.08%))
0.74
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 7.55% + (0.8 * 8.6%)
14.43%

Discounted Cash Flow Calculation for BSE:533210 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Kriti Nutrients is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

BSE:533210 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (INR, Millions) Source Present Value
Discounted (@ 14.43%)
2020 145.48 Est @ 11.45% 127.13
2021 160.44 Est @ 10.28% 122.52
2022 175.61 Est @ 9.46% 117.20
2023 191.22 Est @ 8.89% 111.53
2024 207.45 Est @ 8.49% 105.73
2025 224.47 Est @ 8.21% 99.98
2026 242.45 Est @ 8.01% 94.37
2027 261.53 Est @ 7.87% 88.96
2028 281.87 Est @ 7.77% 83.79
2029 303.59 Est @ 7.71% 78.87
Present value of next 10 years cash flows ₹1,030.09
BSE:533210 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= ₹303.59 × (1 + 7.55%) ÷ (14.43% – 7.55%)
₹4,745.80
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= ₹4,745.80 ÷ (1 + 14.43%)10
₹1,232.85
BSE:533210 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= ₹1,030.09 + ₹1,232.85
₹2,262.94
Equity Value per Share
(INR)
= Total value / Shares Outstanding
= ₹2,262.94 / 50.10
₹45.17
BSE:533210 Discount to Share Price
Calculation Result
Value per share (INR) From above. ₹45.17
Current discount Discount to share price of ₹18.55
= -1 x (₹18.55 - ₹45.17) / ₹45.17
58.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Kriti Nutrients is available for.
Intrinsic value
>50%
Share price is ₹18.55 vs Future cash flow value of ₹45.17
Current Discount Checks
For Kriti Nutrients to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Kriti Nutrients's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Kriti Nutrients's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Kriti Nutrients's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Kriti Nutrients's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BSE:533210 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in INR ₹3.38
BSE:533210 Share Price ** BSE (2019-07-22) in INR ₹18.55
India Food Industry PE Ratio Median Figure of 163 Publicly-Listed Food Companies 16.03x
India Market PE Ratio Median Figure of 2,833 Publicly-Listed Companies 14.48x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Kriti Nutrients.

BSE:533210 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BSE:533210 Share Price ÷ EPS (both in INR)

= 18.55 ÷ 3.38

5.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Kriti Nutrients is good value based on earnings compared to the IN Food industry average.
  • Kriti Nutrients is good value based on earnings compared to the India market.
Price based on expected Growth
Does Kriti Nutrients's expected growth come at a high price?
Raw Data
BSE:533210 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 5.49x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
-8.7%per year
India Food Industry PEG Ratio Median Figure of 18 Publicly-Listed Food Companies 1.54x
India Market PEG Ratio Median Figure of 537 Publicly-Listed Companies 1.26x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Kriti Nutrients, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Kriti Nutrients's assets?
Raw Data
BSE:533210 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in INR ₹13.84
BSE:533210 Share Price * BSE (2019-07-22) in INR ₹18.55
India Food Industry PB Ratio Median Figure of 206 Publicly-Listed Food Companies 0.91x
India Market PB Ratio Median Figure of 3,670 Publicly-Listed Companies 0.93x
BSE:533210 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BSE:533210 Share Price ÷ Book Value per Share (both in INR)

= 18.55 ÷ 13.84

1.34x

* Primary Listing of Kriti Nutrients.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Kriti Nutrients is overvalued based on assets compared to the IN Food industry average.
X
Value checks
We assess Kriti Nutrients's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Food industry average (and greater than 0)? (1 check)
  5. Kriti Nutrients has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Kriti Nutrients expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Kriti Nutrients, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-8.7%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Kriti Nutrients expected to grow at an attractive rate?
  • Kriti Nutrients's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 7.6%.
Growth vs Market Checks
  • Kriti Nutrients's earnings are expected to decrease over the next 1-3 years, this is below the India market average.
  • Unable to compare Kriti Nutrients's revenue growth to the India market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
BSE:533210 Future Growth Rates Data Sources
Data Point Source Value (per year)
BSE:533210 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts -8.7%
India Food Industry Earnings Growth Rate Market Cap Weighted Average 16.3%
India Food Industry Revenue Growth Rate Market Cap Weighted Average 13.1%
India Market Earnings Growth Rate Market Cap Weighted Average 16.9%
India Market Revenue Growth Rate Market Cap Weighted Average 9.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BSE:533210 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in INR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BSE:533210 Past Financials Data
Date (Data in INR Millions) Revenue Cash Flow Net Income *
2019-03-31 4,852 170
2018-12-31 5,040 186
2018-09-30 5,116 199
2018-06-30 4,880 187
2018-03-31 4,607 174 158
2017-12-31 5,134 142
2017-09-30 4,760 100
2017-06-30 4,718 79
2017-03-31 4,565 -177 63
2016-12-31 3,732 69
2016-09-30 3,653 56
2016-06-30 3,582 58

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Kriti Nutrients's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Unable to determine if Kriti Nutrients is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BSE:533210 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Kriti Nutrients Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:533210 Past Financials Data
Date (Data in INR Millions) EPS *
2019-03-31 3.38
2018-12-31 3.70
2018-09-30 3.97
2018-06-30 3.73
2018-03-31 3.15
2017-12-31 2.86
2017-09-30 1.99
2017-06-30 1.58
2017-03-31 1.25
2016-12-31 1.38
2016-09-30 1.14
2016-06-30 1.17

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Kriti Nutrients will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Kriti Nutrients's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the India market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the India market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Kriti Nutrients has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Kriti Nutrients performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Kriti Nutrients's growth in the last year to its industry (Food).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Kriti Nutrients has delivered over 20% year on year earnings growth in the past 5 years.
  • Kriti Nutrients's 1-year earnings growth is less than its 5-year average (7.4% vs 34%)
  • Kriti Nutrients's earnings growth has not exceeded the IN Food industry average in the past year (7.4% vs 15.4%).
Earnings and Revenue History
Kriti Nutrients's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Kriti Nutrients Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BSE:533210 Past Revenue, Cash Flow and Net Income Data
Date (Data in INR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 4,852.28 169.51 83.80
2018-12-31 5,039.61 185.59 90.93
2018-09-30 5,116.40 198.67 89.28
2018-06-30 4,880.42 186.60 87.44
2018-03-31 4,606.74 157.86 84.66
2017-12-31 5,133.52 142.35 85.94
2017-09-30 4,760.49 99.76 84.81
2017-06-30 4,717.96 79.31 83.17
2017-03-31 4,565.36 62.86 80.22
2016-12-31 3,732.00 68.96 76.67
2016-09-30 3,653.07 56.47 75.26
2016-06-30 3,582.42 58.12 73.54
2016-03-31 3,579.23 62.94 72.49
2015-12-31 3,343.08 51.05 145.59
2015-09-30 3,351.51 77.76 143.78
2015-06-30 3,228.32 68.57 142.71
2015-03-31 3,103.99 57.59 66.82
2014-12-31 3,000.52 52.13 124.36
2014-09-30 2,913.01 30.80 123.07
2014-06-30 2,940.03 43.24 50.66
2014-03-31 2,884.69 35.65 121.05
2013-12-31 3,523.93 41.83 218.86
2013-09-30 4,813.57 45.56 219.81
2013-06-30 4,828.98 7.33 48.45
2013-03-31 4,663.08 10.52 218.99
2012-09-30 4,103.94 16.21 295.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Kriti Nutrients has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Kriti Nutrients used its assets more efficiently than the IN Food industry average last year based on Return on Assets.
  • Kriti Nutrients has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Kriti Nutrients's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Kriti Nutrients has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Kriti Nutrients's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Kriti Nutrients's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Kriti Nutrients is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Kriti Nutrients's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Kriti Nutrients's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Kriti Nutrients Company Filings, last reported 3 months ago.

BSE:533210 Past Debt and Equity Data
Date (Data in INR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 691.12 123.56 19.12
2018-12-31 624.21 140.10 19.26
2018-09-30 624.21 140.10 19.26
2018-06-30 535.09 295.86 9.94
2018-03-31 535.09 295.86 9.94
2017-12-31 433.62 411.71 8.01
2017-09-30 433.62 411.71 8.01
2017-06-30 383.27 358.02 19.34
2017-03-31 382.37 358.02 2.80
2016-12-31 345.82 115.10 18.41
2016-09-30 345.82 115.10 18.41
2016-06-30 326.80 153.08 18.23
2016-03-31 326.80 153.08 18.23
2015-12-31 295.81 122.84 19.43
2015-09-30 295.81 122.84 19.43
2015-06-30 266.16 218.63 18.57
2015-03-31 266.16 213.05 18.57
2014-12-31 224.06 186.38 18.88
2014-09-30 224.06 186.38 18.88
2014-06-30 216.25 202.49 16.56
2014-03-31 216.25 211.73 15.01
2013-12-31 199.60 242.60 21.52
2013-09-30 199.60 242.60 21.52
2013-06-30 184.17 211.84 22.69
2013-03-31 184.17 193.50 22.69
2012-09-30
  • Kriti Nutrients's level of debt (17.9%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (97.9% vs 17.9% today).
  • Debt is well covered by operating cash flow (140.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 11.7x coverage).
X
Financial health checks
We assess Kriti Nutrients's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Kriti Nutrients has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Kriti Nutrients's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.97%
Current annual income from Kriti Nutrients dividends.
If you bought ₹2,000 of Kriti Nutrients shares you are expected to receive ₹19 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Kriti Nutrients's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.57%).
  • Kriti Nutrients's dividend is below the markets top 25% of dividend payers in India (2.29%).
Upcoming dividend payment

Purchase Kriti Nutrients before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BSE:533210 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
India Food Industry Average Dividend Yield Market Cap Weighted Average of 70 Stocks 0.9%
India Market Average Dividend Yield Market Cap Weighted Average of 1446 Stocks 1.5%
India Minimum Threshold Dividend Yield 10th Percentile 0.3%
India Bottom 25% Dividend Yield 25th Percentile 0.6%
India Top 25% Dividend Yield 75th Percentile 2.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BSE:533210 Past Annualized Dividends Data
Date (Data in ₹) Dividend per share (annual) Avg. Yield (%)
2019-05-16 0.180 0.792
2018-07-04 0.180 0.549
2018-05-16 0.180 0.488
2017-08-14 0.120 0.393
2017-05-19 0.120 0.690
2016-03-14 0.120 0.672
2015-08-11 0.100 0.598
2015-05-20 0.100 1.282
2014-09-01 0.100 1.968
2014-06-04 0.100 2.384
2013-09-16 0.060 1.918
2012-08-23 0.150 3.287
2011-09-27 0.150 3.116

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Kriti Nutrients has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Kriti Nutrients only paid a dividend in the past 8 years.
Current Payout to shareholders
What portion of Kriti Nutrients's earnings are paid to the shareholders as a dividend.
  • Dividends paid are thoroughly covered by earnings (18.8x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Kriti Nutrients's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Kriti Nutrients afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Kriti Nutrients has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Kriti Nutrients's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Shiv Mehta
COMPENSATION ₹0
AGE 65
CEO Bio

Mr. Shiv Singh Mehta, B.E., MBA is a Co-Founder of Kriti Industries (India) Ltd. and serves as its Managing Director. Mr. Mehta has been Managing Director of Kriti Industries (India), Solvent Division (AKS Kriti Nutrients Ltd.) since June 30, 2010. He has been Chairman of the Board for Kriti Nutrients Limited since July 31, 2018. He has over 15 years of diverse experience in the Corporate Sector. His expertise in Specific areas include: Finance, Marketing, technical and Business Administration. He has been Executive Director of Kriti Industries (India) Ltd. since March 12, 1990 and Kriti Nutrients Limited (alternate name is Kriti Industries (India), Solvent Division) since December 26, 2009. He served as a Director of Rajratan Global Wires Limited. Mr. Mehta has a B.E. and an M.B.A.

CEO Compensation
  • Insufficient data for Shiv to compare compensation growth.
  • Shiv's remuneration is lower than average for companies of similar size in India.
Management Team

Shiv Mehta

TITLE
Chairman & MD
AGE
65

Suresh Jajoo

TITLE
CFO & Compliance Officer
COMPENSATION
₹3M
TENURE
4.8 yrs

Saurabh Mehta

TITLE
Whole-Time Director
COMPENSATION
₹8M
AGE
38
Board of Directors Tenure

Average tenure and age of the Kriti Nutrients board of directors in years:

7.5
Average Tenure
61.5
Average Age
  • The tenure for the Kriti Nutrients board of directors is about average.
Board of Directors

Shiv Mehta

TITLE
Chairman & MD
AGE
65
TENURE
1 yrs

Saurabh Mehta

TITLE
Whole-Time Director
COMPENSATION
₹8M
AGE
38
TENURE
9.6 yrs

Purnima Mehta

TITLE
Director
COMPENSATION
₹85K
AGE
59
TENURE
9.6 yrs

Manoj Fadnis

TITLE
Independent Non-Executive Director
COMPENSATION
₹85K
AGE
57
TENURE
9.6 yrs

Rakesh Kalra

TITLE
Independent & Non-Executive Director
COMPENSATION
₹85K
AGE
70
TENURE
5.5 yrs

Chandrasekharan Bhaskar

TITLE
Additional Independent Director
AGE
64
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (₹) Value (₹)
X
Management checks
We assess Kriti Nutrients's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Kriti Nutrients has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Kriti Nutrients Limited engages in the processing, extraction, and production of soya crude/refined oils and products under the KRITI brand in India. The company’s products include superhypro meals, defatted soya flakes, and lecithin for use in human consumption, cattle feed, poultry, aquaculture, confectionary, dairy product, and industrial applications, as well as for pharmaceutical preparations. It also offers sun flower oil, soya flour, super hypro SBMs, soy meals, and soya grits. In addition, the company exports its products. The company was incorporated in 1996 and is based in Indore, India. Kriti Nutrients Limited is a subsidiary of Sakam Trading Private Limited.

Details
Name: Kriti Nutrients Limited
533210
Exchange: BSE
Founded: 1996
₹944,451,352
50,103,520
Website: http://kritinutrients.com
Address: Kriti Nutrients Limited
Chetak Chambers,
4th Floor,
Indore,
Madhya Pradesh, 45201,
India
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BSE 533210 Equity Shares Mumbai Stock Exchange IN INR 29. Jun 2010
Number of employees
Current staff
Staff numbers
224
Kriti Nutrients employees.
Industry
Packaged Foods and Meats
Food, Beverage & Tobacco
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/22 13:04
End of day share price update: 2019/07/22 00:00
Last earnings filing: 2019/05/16
Last earnings reported: 2019/03/31
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.